03/03/2026
In this enlightening video, Dr. Parveen Kundu β MBBS (AIIMS), MD (Nuclear Medicine, AIIMS), FANMB, FEBNM β a leading authority in Nuclear Medicine and Theranostics, explains the science, safety, and success of PRRT (Peptide Receptor Radionuclide Therapy). PRRT is a cutting-edge, targeted therapy used to treat Neuroendocrine Tumors (NETs), offering improved quality of life and longer survival for patients. Dr. Kundu breaks down how this advanced nuclear medicine technique works by delivering radiation directly to cancer cells while minimizing damage to healthy tissues. π― Key Topics Covered in the Video: βοΈ What is PRRT and how it works βοΈ Who can benefit from PRRT β patient eligibility and tumor types βοΈ Treatment process and safety profile βοΈ Clinical effectiveness and patient outcomes βοΈ Role of RNM Centre in delivering PRRT with global standards β¨ Why Watch? This video is a must-watch for patients, caregivers, and medical professionals seeking to understand the potential of PRRT in managing complex neuroendocrine tumors. πPRRT is available at RNM Centre β Theranostics Cancer Center, a leading Centre for Nuclear Medicine Therapy and Theranostics in India. π Like, share, and subscribe to our channel for more expert talks and patient-centered insights into advanced cancer care. π GET IN TOUCH π Address: Rohtak Nuclear Medicare Imaging Therapy & Research Center Vinay Nagar, Gali No. 5, Opp. Tau Devi Lal Park, Main Delhi Northern Highway, Rohtak, Haryana β 124001. π Call Us: +91 83073 55621 | 01262-262406 π² Follow Us πΉ Facebook: bit.ly/3hZShDH πΉ Instagram: bit.ly/3EAgSGK πΉ Website: rnmcenter.com